REPORTS

Let’s Pullulate and Expand Your Business

Buprenorphine Transdermal Patches Market - Global Professional Analysis and Forecast to 2026

Nov 15, 2019  |  137 PAGES  |  REPORT CODE: CMM238182
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Buprenorphine Transdermal Patches market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.1% during the forecast period.

This report presents the market size and development trends by detailing the Buprenorphine Transdermal Patches market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Buprenorphine Transdermal Patches market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Buprenorphine Transdermal Patches industry and will help you to build a panoramic view of the industrial development.

Buprenorphine Transdermal Patches Market, By Type:

  • 5mcg/h

  • 7.5mcg/h

  • 10mcg/h

  • 15 mcg/h

  • 20 mcg/h

Buprenorphine Transdermal Patches Market, By Application:

  • Moderate to severe pain of cancer

  • Severe pain of invalid Non-opioid analgesics

Some of the leading players are as follows:

  • Luye Pharma

  • Grunenthal

  • PurduePharma

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Buprenorphine Transdermal Patches Market: Technology Type Analysis

  • 4.1 Buprenorphine Transdermal Patches Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Buprenorphine Transdermal Patches Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 5mcg/h

    • 4.3.2 7.5mcg/h

    • 4.3.3 10mcg/h

    • 4.3.4 15 mcg/h

    • 4.3.5 20 mcg/h

5 Buprenorphine Transdermal Patches Market: Product Analysis

  • 5.1 Buprenorphine Transdermal Patches Product Market Share Analysis, 2018 & 2026

  • 5.2 Buprenorphine Transdermal Patches Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Buprenorphine Transdermal Patches Market: Application Analysis

  • 6.1 Buprenorphine Transdermal Patches Application Market Share Analysis, 2018 & 2026

  • 6.2 Buprenorphine Transdermal Patches Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Moderate to severe pain of cancer

    • 6.3.2 Severe pain of invalid Non-opioid analgesics

7 Buprenorphine Transdermal Patches Market: Regional Analysis

  • 7.1 Buprenorphine Transdermal Patches Regional Market Share Analysis, 2018 & 2026

  • 7.2 Buprenorphine Transdermal Patches Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Luye Pharma

    • 9.1.1 Luye Pharma Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Grunenthal

    • 9.2.1 Grunenthal Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 PurduePharma

    • 9.3.1 PurduePharma Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

 

The List of Tables and Figures (Totals 63 Figures and 152 Tables)

  • Figure 5mcg/h Buprenorphine Transdermal Patches market, 2015 - 2026 (USD Million)

  • Figure 7.5mcg/h Buprenorphine Transdermal Patches market, 2015 - 2026 (USD Million)

  • Figure 10mcg/h Buprenorphine Transdermal Patches market, 2015 - 2026 (USD Million)

  • Figure 15 mcg/h Buprenorphine Transdermal Patches market, 2015 - 2026 (USD Million)

  • Figure 20 mcg/h Buprenorphine Transdermal Patches market, 2015 - 2026 (USD Million)

  • Figure Moderate to severe pain of cancer market, 2015 - 2026 (USD Million)

  • Figure Severe pain of invalid Non-opioid analgesics market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Buprenorphine Transdermal Patches market, by country, 2015 - 2026 (USD Million)

  • Table North America Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table North America Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table North America Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Canada Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Canada Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Europe Buprenorphine Transdermal Patches market, by country, 2015 - 2026 (USD Million)

  • Table Europe Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Europe Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Europe Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Germany Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Germany Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table France Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table France Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Italy Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Italy Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Spain Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Spain Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Buprenorphine Transdermal Patches market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table China Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table China Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Japan Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Japan Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table India Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table India Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Buprenorphine Transdermal Patches market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table MEA Buprenorphine Transdermal Patches market, by country, 2015 - 2026 (USD Million)

  • Table MEA Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table MEA Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table MEA Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Buprenorphine Transdermal Patches market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Buprenorphine Transdermal Patches market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Buprenorphine Transdermal Patches market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Luye Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Grunenthal Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table PurduePharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top